USPTO serial 79400159
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MICHELLE LEVIN
MICHELLE LEVIN Leason Ellis LLPOne North Lexington Ave., Suite 1200White Plains, NY 10601United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biological and biochemical products for industrial, scientific purposes, namely, peptides, fluorescent dyes and conjugates thereof for use in separation processes for biological materials; reagents for cell separation; reagents for DNA, RNA, and polynucleotide detection; reagents for amplification, sequencing and detection of genetic material; reagents for Polymerase Chain Reaction (PCR); in situ polynucleotide detection reagents; in situ hybridization (ISH) reagents; fluorescence in situ hybridization (FISH) reagents; polynucleotide hybridization reagents; spatial multi-omics reagents; spatial transcriptomics reagents; polynucleotide detection probes; labeling reagents; media for cell culture for research laboratories; substances and ingredients for the preparation of media; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of chemical and biological material; reagents with magnetic beads; tissue staining reagents; antibody reagents used for the detection of antigens in cells and tissue, other than for medical or veterinary purposes; buffer solutions and reagents for use with laboratory instruments, namely, imaging instruments, reagents for processing of biological material, namely, tissue, bone marrow, cells, blood other than for medical or veterinary purposes; culture media, cell culture media, freezing media, contrast agents, contrast agents for in-vivo imaging, all for scientific purposes; reagents for use in biotechnology, and in the biotechnology industry; enzymes, other than for medical or veterinary use; polynucleotides, polynucleotide, DNA, and RNA primers and probes, fluorescence primers and probes, fluorophores, chemical additives for dyeing, all for scientific purposes; all the above for industrial or scientific purposes | ACTIVE | — |
| 002 | Primers and surgical dyes for use in pharmaceutical or scientific industries | ACTIVE | — |
| 005 | Nucleotides, polynucleotides, polynucleotides, namely, primers or probes for dna and rna, fluorescence primers and probes, complexes of molecules; all for medical purposes | ACTIVE | — |
| 009 | Apparatus for imaging for use in the study of spatial biology imaging; Scientific laboratory research instruments for polynucleotide sequencing; scientific laboratory research instruments for amplification and detection of genetic material; scientific laboratory research instruments for tissue visualization, in situ hybridization (ISH) instruments, fluorescence in situ hybridization (FISH) instruments; Scientific apparatus, namely, for spatial multi-omics and spatial transcriptomics for use in the science industry; apparatus for histology, namely, fluorescent imaging apparatuses and microscopes all for scientific purposes; histopathology slides and chambers; all the aforesaid being for laboratory use | ACTIVE | — |
| 010 | Medical imaging apparatus; instruments for spatial biology; instruments for polynucleotide sequencing; instruments for amplification and detection of genetic material; instruments for tissue visualization, in situ hybridization (ISH) instruments, fluorescence in situ hybridization (FISH) instruments; Polymerase Chain Reaction (PCR) instruments; apparatus for spatial multi-omics and spatial transcriptomics; apparatus for histology, all for medical and diagnostic purposes; histopathology slides and chambers; columns for analysis for medical purposes; all the aforementioned for medical purposes; apparatus and instruments for medical purposes | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design services; services for design of polynucleotide probes and genetic panels; all of the aforementioned services for and in connection with detection, localization and analysis of proteins and genetic material for biological and medical research, medical diagnostics and therapy | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 1, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 17, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 17, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 18, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 18, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 18, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 19, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 2, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 2, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 1, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 31, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 31, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 12, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 12, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 23, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 1, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 25, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 25, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 25, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 9, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 22, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 22, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 16, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 15, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 14, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 25, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 25, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 18, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |